Medicine
Pazopanib 200 mg tablet
Pazopanib 200 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Pazopanib
- Brand
- Sold under the generic name
- Strength
- 200 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 120 tablets, 30 tablets, 90 tablets and 8 more
- Manufacturers
- Aurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaApotexAvKAREGolden State Medical SupplyNovugen PharmaTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XE11 Pazopanib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 October 2023
- Identifiers
- RxCUI 867502DailyMed set ID 115eb5bb-1403-fb3d-e063-6394a90ad320, d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5, 25575cc6-5757-4f9b-9c09-0c4deb61ba12 +4NDC 51407-872, 63304-116, 59651-582 +4Application ANDA217713, ANDA215837, ANDA219034 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 120 tablet, film coated in 1 bottle | 59651-582-08 | Aurobindo PharmaIndia | 4 December 2024 |
| 30 tablet, film coated in 1 bottle | 59651-582-30 | Aurobindo PharmaIndia | 4 December 2024 |
| 90 tablet, film coated in 1 bottle | 59651-582-90 | Aurobindo PharmaIndia | 4 December 2024 |
| 120 tablet, film coated in 1 bottle | 63304-116-13 | Sun Pharmaceutical IndustriesIndia | 20 October 2023 |
| 30 tablet, film coated in 1 bottle | 63304-116-30 | Sun Pharmaceutical IndustriesIndia | 20 October 2023 |
| 500 tablet in 1 bottle | 60505-4779-5 | Apotex | 19 October 2023 |
| 120 tablet in 1 bottle | 60505-4779-7 | Apotex | 19 October 2023 |
| 120 tablet, film coated in 1 bottle | 82293-022-10 | Novugen Pharma | 24 April 2024 |
| 120 tablet, film coated in 1 bottle | 0480-4184-89 | Teva Pharmaceuticals | 20 October 2023 |
| 120 tablet, film coated in 1 bottle | 42291-939-12 | AvKARE | 23 April 2024 |
| 120 tablet in 1 bottle | 51407-872-12 | Golden State Medical Supply | 8 January 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pazopanib 200 mg tablet.
Other strengths and forms of Pazopanib
Clinical summary
Pazopanib is a kinase inhibitor indicated for the treatment of adults with advanced renal cell carcinoma (RCC), among other approved uses. It is available as tablets for oral use. MedsAcross supplies Pazopanib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PazopanibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VOTRIENT prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Votrient: European public assessment report (EPAR) · European Medicines Agency
Need Pazopanib 200 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.